Cudarolimab (Anti-TNFRSF4 / OX40 / CD134)

Synonyms: IBI101

Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) is an agonistic fully human anti-OX40 (tumor necrosis factor receptor superfamily member 4, TNFRSF4, CD134, OX40L receptor) with potential immune checkpoint inhibitory and antineoplastic activities. MW : 145.94 KD.

Cudarolimab (Anti-TNFRSF4 / OX40 / CD134)

Purity & Quality Control

Batch: A281401 Purity: 99% Protein concentration: 10.36mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective OX Receptor Inhibitors

Biological Activity

Description Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) is an agonistic fully human anti-OX40 (tumor necrosis factor receptor superfamily member 4, TNFRSF4, CD134, OX40L receptor) with potential immune checkpoint inhibitory and antineoplastic activities. MW : 145.94 KD.

Product Details

CAS No. 2244739-29-3
Molecular Weight 145.94
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) | Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) supplier | purchase Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) | Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) cost | Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) manufacturer | order Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) | Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) distributor